iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
(iGlucose Trial)
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: The University of Texas Health Science Center, Houston
Trial Summary
What is the purpose of this trial?The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT
Eligibility Criteria
Inclusion Criteria
All patients >/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks.
Non-anomalous singletons
Ability to provide informed consent
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: iGlucose Smart MeterExperimental Treatment1 Intervention
Group II: Rx glucose meterPlacebo Group1 Intervention
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
The University of Texas Health Science Center at HoustonHouston, TX
Loading ...
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, HoustonLead Sponsor
Smart Meter CorporationIndustry Sponsor